Top

Published in:

Open Access 01-12-2014 | Oral presentation

A company experience of the first MoCA pilot project

Author: Wills Hughes-Wilson

Published in: Orphanet Journal of Rare Diseases | Special Issue 1/2014

Excerpt

Pricing and reimbursement authorities often lack sufficient information to decide about Orphan Medicinal Products (OMPs), because of pricing, high levels of uncertainty and small datasets, amongst others. EU Member States share similar challenges as they seek to include OMPs appropriately in their healthcare systems. …

Title: A company experience of the first MoCA pilot project
Author: Wills Hughes-Wilson
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue Special Issue 1/2014
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-9-S1-O26

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A company experience of the first MoCA pilot project

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2014

The RE(ACT) Initiative and the use of an online community to enhance research on rare diseases

Health care cost-containment measures in the context of the economic crisis: impact analysis

OSSE – open source registry software solution

Understanding off-label use and the new challenges

European Network of Rare Disease Help Lines (ENRDHLs) – caller profile analysis 2013

Are we ready? What is missing and what is needed? A regulator’s perspective